U.S. pharma giant copyright scrapped two experimental weight loss capsules past year—a at the time-daily capsule, lotiglipron, as a result of elevated liver enzymes and also a 2 times-daily pill, danuglipron, on account of potent Unwanted side effects—but CEO Albert Bourla has claimed the company is determined to “Engage in and earn” during